[Administration of prostacyclin in sudden deafness. Evaluation with the double blind method].
Prostacyclin (PGI2) connects all the pharmacologic properties of drugs being used till now in sudden deafness. 30 patients with sensori-neural sudden deafness were treated by prostacyclin and placebo in the double-blind test situation. In therapeutic group of 15 patients were 87% of complete recovery, but in placebo only 6%.
Olszewski
E
E
Kliniki Otolaryngologii AM w Krakowie.
Kostka-Trabka
E
E
Reroń
E
E
Grodzińska
L
L
Turek
J
J
Dembińska-Kieć
A
A
Bieroń
K
K
Basista
M
M
Kedzior
A
A
Sławiński
M
M
D000328:Adult; D000368:Aged; D004311:Double-Blind Method; D011464:Epoprostenol / Q000627:therapeutic use*; D005260:Female; D003639:Hearing Loss, Sudden / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged
D011464:Epoprostenol
Zastosowanie prostacykliny w nagłej głuchocie. Ocena metoda "podwójnie ślepej próby".